no results
Ihre Produkte genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich mit Ihren Produkten und Leistungen auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihre Produkte und Dienstleistungen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
no results
Ihr Unternehmen genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihr Unternehmen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
Prostate stents
In the past, the prostate stent market was dominated by North America. Then, other regions, such as Europe and Asia Pacific, saw growth, including Latin America and the Middle East and Africa. Although North America remained the largest region, the Asia Pacific and Latin American regions are expected to show promising growth in the next few years owing to rising healthcare awareness and the increasing geriatric population. However, there are some drawbacks to this approach, which should be taken into account before investing in prostate stent technology.
A recent study found that the global market for prostate stents is expected to grow at a compound annual rate of 8.5% through 2024. The growth of the prostate stent market can be attributed to several factors. The increasing incidence of benign prostatic hyperplasia, the aging population, urbanization, and technological advancements by manufacturers are expected to drive growth in the next few years. For example, the emergence of robotic assisted minimally invasive procedures may help doctors detect cancer earlier, while reducing the length of stay in hospital. Similarly, mergers and acquisitions are likely to boost the growth of the prostate stent market.
The global prostate stents market is divided into hospitals, clinics, and others. The hospitals segment accounted for the largest share of the market in 2017, followed by clinics and academic & research institutes. The patients in these three segments have similar prostatic urethral lengths, so it is important to adjust the size of the stents for the length of the patient's urethra.
Biodegradable stents are also used for recurrence. The SR-PLLA stent material has a 1-year biodegradation time, which means that the patient can benefit from the maximum finasteride effect. An open, non-randomized pilot study of 11 patients with BPE has revealed promising results. At 2 weeks, all patients had spontaneous voiding. The mean follow-up was twenty-four months. Of the 11 patients, three required surgery, and two had a negative experience.
Aside from the side effects, prostate stents also have several advantages. They are a good way to improve quality of life in men. Studies show that stents can reduce the number of hospitalizations. Unlike the traditional surgery, this procedure doesn't require anesthesia. The stents are usually implanted within the prostatic urethra, and there is no need for surgery.
The present invention relates to self-expandable spiral prostatic stents that are useful for opening blocked prostatic urethras. The SR-PLLA 96/4 with barium is a stent that can be implanted in the prostate and simulate the function of definitive surgical intervention. The stents have many advantages, and the stents can be used to treat an enlarged prostate.